ghk-cu downregulates inflammatory genes Peptide Therapy for Inflammation: A New Solution GHK-Cu Peptide Therapy: The Definitive
Description
Q: Does this mean peptides like BPC-157 are now FDA-approved
Thanks to its antioxidant and anti-inflammatory properties, including its ability to regulate copper, the peptide is being explored as a potential treatment for conditions such as Alzheimers, Parkinsons, and cognitive decline related to aging (8)
Multi-dose Vials: For ongoing therapy under medical supervision
Additionally, this study was designed to investigate safety and tolerability, thus secondary weight management outcomes must be interpreted in context
